TraceLink’s serialization customer count approached 400 in 2017.
TraceLink Inc. announced that as of the end of 2017, 394 pharmaceutical and contract manufacturing customers have selected the company’s serialization options to comply with regulations in the U.S., Europe, China, India, and South Korea.
The company said it added 75 new pharmaceutical and contract manufacturing (CMO) customers in Q4 of 2017, with 50 new manufacturing customers added in the month of December. It attributes year-over-year increases to its Life Sciences Cloud network, a multi-tenant solution for digitizing the global pharmaceutical supply chain.
EMEA-based companies represented 73 percent of the new manufacturing customers during the fourth quarter. Demand for serialization solutions continues to accelerate as the global pharmaceutical industry moves to comply with the February 2019 deadline for the EU Falsified Medicines Directive, as well as current requirements under the U.S. Drug Supply Chain and Security Act (DSCSA).
(Source: TraceLink Inc.)
